Search

everythinglearnresearchcommunity

for

Search:↓

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Persistent ED in Propecia users is not due to abnormal blood flow.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Finasteride may be cost-effective for preventing prostate cancer in high-risk groups.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Doxazosin mesylate and saw palmetto cause genetic changes in fruit flies.

Finasteride use may be linked to rare testicular tumor, but more research needed.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.